Chromosome Allele Loss in Fibrolamellar Carcinoma
Author Information
Author(s): S.-F. Ding, J.D.A. Delhanty, L. Bowles, J.S. Dooley, C.B. Wood, N.A. Habib
Primary Institution: Royal Postgraduate Medical School, Hammersmith Hospital
Hypothesis
The study investigates the frequency of chromosome allele loss in fibrolamellar carcinoma compared to hepatocellular carcinoma.
Conclusion
The frequency of allele loss in fibrolamellar carcinoma is significantly lower than in hepatocellular carcinoma.
Supporting Evidence
- Two of the probes showed allele losses in one tumour.
- The frequency of allele loss in FLC was much lower than in HCC.
- FLC has a better prognosis than HCC with an average survival of 44 months compared to 6 months.
Takeaway
This study looked at a rare liver cancer and found that it loses fewer genetic markers compared to a more common type of liver cancer, which might explain why it has a better outlook for patients.
Methodology
The study used 18 DNA probes to analyze chromosome allele loss in surgical biopsies from patients with fibrolamellar carcinoma.
Limitations
The study had a small sample size due to the rarity of fibrolamellar carcinoma.
Participant Demographics
Patients were aged 19 to 60, with an equal sex incidence.
Statistical Information
P-Value
0.03
Statistical Significance
p=0.03
Want to read the original?
Access the complete publication on the publisher's website